This is the authors' abstract. We don't add key points for this paper.
A new polyhedral oligomeric silsesquioxane (POSS) methacrylate monomer, 1-(3-(methacryloyloxy)propyl)dimethylsiloxy-3,5,7,9,11,13,15-hepta(isobutyl)pentacyclo-[9.5.1.1 3,9 .1 5,15 .1 7,13 ]octasiloxane ((i-Bu) 7 POSS-OSiMe 2 -MA, 1 ), with a flexible spacer between the cubic POSS cage and methacrylate group was synthesized to reduce steric strain and thus achieve polymethacrylates (poly(POSS-MA)s) with high molecular weight (MW). Atom transfer radical polymerization (ATRP) of 1 at high monomer concentration (1 M, corresponding to ca. 85 wt % of 1 ) led to polymers with the absolute number-average MW, determined by multiangle laser light scattering, M n, MALLS = 2 350 000 (and apparent MW, measured by gel permeation chromatography with linear poly(methyl methacrylate) (PMMA) standards, M n,GPC = 550 000). Optimization of the reaction conditions, including the ATRP catalyst, targeted degrees of polymerization, monomer concentrations, as well as a monomer feeding, resulting in the first well-defined high MW polymers with POSS moieties.
No takes yet. Share an insight, caveat, or question.
Franczyk et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: